ストックスクリーナーアプリを入手
3.11
2.20%
-0.07
Pepgen Inc (PEPG) 最新ニュース
PepGen (PEPG) Financial Update: The Bottom-Line Figure Beats Its Comparison on the Day; Trading Move - vinanet.vn
PepGen (PEPG) Financial Update: The Bottom-Line Figure Beats Its Comparison on the Day; Trading Move: Shares Finish 0.98% Higher on the DayShare Repurchase Impact - dars.gov.et
GSA Capital Partners LLP Makes New Investment in PepGen, Inc. $PEPG - MarketBeat
PEPG Q2 2026 Earnings: Narrower Loss Beats Estimates as Pipeline Progress ContinuesEBITDA Analysis - Vinanet
PepGen, Inc. (NASDAQ:PEPG) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
PepGen’s DM1 Bet Runs Into An FDA Hold And Dilution Fears - Finimize
PepGen Inc. (PEPG) Slips 1.17% to $2.94 as Biotech Stock Holds Above Key SupportUp Down Volume - vinanet.vn
PepGen (PEPG) Climbs 1.21% as Shares Approach Key $3.09 Resistance ZoneHigh Volume Stocks - vinanet.vn
Here's Why We're Watching PepGen's (NASDAQ:PEPG) Cash Burn Situation - Moomoo
PepGen identifies muscle weakness and myotonia as drivers of speech challenges in DM1 - Traders Union
HC Wainwright Has Positive Outlook of PepGen FY2027 Earnings - MarketBeat
Weekly Recap: 12.5/10 mg/kg dose escalation and Q4 2027 cash runway - TradingView
PepGen Inc. (PEPG) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of August 8, 2025 Deadline - The National Law Review
PepGen (NASDAQ:PEPG) Posts Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
PepGen Inc. Stock 12‑Month Price Target Cut to $10.19, Implies 323% Upside - TradingView
PepGen Inc (PEPG) Stock News Today - TradingKey
PepGenCash of $117.20 Mln as of June 30, 2 - Moomoo
PepGen Maintained at Buy as Analyst Cites Encouraging DM1 Safety/Efficacy Profile and Keeps $20 Price Target - TipRanks
H.C. Wainwright Maintains PepGen(PEPG.US) With Buy Rating, Maintains Target Price $20 - Moomoo
PepGen advances DM1 trial to highest dose cohort - Investing.com
PepGen Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Craig-Hallum Maintains PepGen(PEPG.US) With Buy Rating, Maintains Target Price $11 - moomoo.com
PepGen advances DM1 trial to highest dose cohort By Investing.com - Investing.com South Africa
PepGen Advances PGN-EDODM1 Trial and Strengthens Finances - TipRanks
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights - biospace.com
PepGen Q2 net loss narrows as expenses fall - TradingView
PepGen Posts $17.8 Million Q2 Loss as Cash Reaches $117.2 Million - Quiver Quantitative
PepGen Inc. 1H 2026: Net loss $(35.6M), EPS $(0.51) — 10-Q Summary - TradingView
PGN-EDODM1 enters top dose group in new PepGen study - Traders Union
BRIEF-PepGen Q2 EPS USD -0.26 - TradingView
PepGen to Advance PGN-EDODM1 Into Highest Dose Cohort in Phase 2 FREEDOM2-DM1 Study Following DSMB Review - Yahoo Finance
Class Action Filed Against PepGen Inc. (PEPG) Over Securities ViolationsContact Levi & Korsinsky Today - The National Law Review
PepGen Inc. (PEPG) Climbs 2.66% to $1.93 as Traders Eye Key Resistance at $2.03Revenue Growth Stocks - Vinanet
PepGen Inc expected to post a loss of 29 cents a shareEarnings Preview - TradingView
Shareholders of PepGen Should Contact Faruqi & Faruqi Before August 11, 2025 to Discuss Your RightsPEPG - TMX Newsfile
PEPG Q1 2026 Earnings: Narrower-than-Expected Loss Signals Cost Discipline Amid Pipeline AdvancementRevenue Recognition Risk - vinanet.vn
PepGen: PGN-EDODM1 Multisystem Efficacy Potential Supports Buy Rating with Unchanged $20 Price Target - TipRanks
PepGen Inc. Revenue Breakdown – NASDAQ:PEPG - TradingView
PEPG Q2'26 Earnings: revenue estimate is 0 USD - TradingView
ADAR1 Capital Management LLC Purchases 1,570,796 Shares of PepGen, Inc. $PEPG - MarketBeat
PepGen Inc (PEPG) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
PepGen Inc (PEPG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
PepGen Inc (PEPG) Cash Flow - TradingKey
Commodore Capital LP Increases Stock Position in PepGen, Inc. $PEPG - MarketBeat
Recover Investment Losses: Levi & Korsinsky Files Class Action Against PepGen Inc. (PEPG) - The National Law Review
PepGen Inc (PEPG) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
PepGen Inc (PEPG) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
PepGen Inc (PEPG) Income Statement - TradingKey
PepGen Inc (PEPG) Institutional Confidence - TradingKey
PepGen Inc (PEPG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PEPG|PepGen Inc|Price:1.890|Chg%:-0.040 - TradingKey
PEPG Q1 2026 Earnings: Narrowed Losses Reflect Cost Discipline Despite Stock PullbackRevenue Inflection Point - vinanet.vn
PepGen Inc (PEPG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
PEPG|PepGen Inc|Price:2.950|Chg%:-0.030 - TradingKey
Why PEPG, SGMO, PHR Are Among Top Premarket Losers Today - Stocktwits
PepGen, Inc. (NASDAQ:PEPG) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
PepGen (NASDAQ:PEPG) Shares Down 2.2%What's Next? - MarketBeat
PepGen Inc. (PEPG) Holds Steady at $2.25 as Stock Tests Key Technical LevelsThrowback Trade - dars.gov.et
PepGen Inc. (PEPG) Holds Steady at $2.25 Amid ConsolidationRange Breakout - dars.gov.et
PEPG Q1 2026 Earnings: EPS Beat Surprises as Pre-Revenue Biotech Focuses on Pipeline ProgressAnalyst Drop Coverage - vinanet.vn
PepGen (PEPG) Edges Lower, Holding Near Key Support ZonePut Flow Alert - dars.gov.et
PepGen Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive Stock ReactionQuarterly Earnings Report - dars.gov.et
PepGen Inc. (PEPG) Edges Higher as Stock Holds Above Key SupportVolume Weighted Price - dars.gov.et
0.86%
0.31%
大文字化:
|
ボリューム (24 時間):